Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction
Mihai Gheorghiade(Northwestern University), Sanjiv J. Shah(National Heart Lung and Blood Institute), Stephen J. Greene(Duke University), Burkert Pieske(German Centre for Cardiovascular Research), Katharina Müller(Ludwig-Maximilians-Universität München), Piotr Ponikowski(Wroclaw Medical University), Gerasimos Filippatos(National and Kapodistrian University of Athens), Lothar Roessig(Bayer (Germany)), Scott D. Solomon(Brigham and Women's Hospital), Eliana T. Samano, Carolyn S.P. Lam, Javed Butler(Emory University), Aldo P. Maggioni, Elisabeth Kraigher‐Krainer(Charité - Universitätsmedizin Berlin)
Cited by 389
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k